Therapy News and Research

RSS

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

20 Apr 2023

Study explores the culture of antibiotic prescribing in US hospital ICUs

In the United States, physicians in almost every specialty and role use antibiotics as part of their therapeutic armamentariums.

20 Apr 2023

Houston-based cancer survivor donates $10 million to accelerate translational research and clinical trials

Vijay Goradia, a Houston-based businessman, philanthropist, and cancer survivor, has donated $10 million to The University of Texas MD Anderson Cancer Center to speed translational research and clinical trials.

20 Apr 2023

Using engineered stem cells to treat ALS and retinitis pigmentosa

Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments.

20 Apr 2023

Are high-power chargers for electric vehicles safe for individuals with cardiac implantable electronic devices?

Researchers examined electromagnetic interference (EMI) risk for patients with cardiac implantable electronic devices (CIEDs)

20 Apr 2023

Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients

Research reports the results of a randomized, placebo-controlled trial that investigated the effects of combining fluvoxamine and inhaled budesonide for preventing disease progression in high-risk outpatients with COVID-19. The study found that the combination treatment reduced the incidence of severe disease requiring advanced care.

20 Apr 2023

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

In a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.

19 Apr 2023

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

UC Davis Health researchers have dosed the second participant in their clinical trial looking to identify a potential cure for HIV utilizing CAR T-cell therapy.

19 Apr 2023

Mind-body linkage is built into the structure of the brain, study reveals

Calm body, calm mind, say the practitioners of mindfulness. A new study by researchers at Washington University School of Medicine in St. Louis indicates that the idea that the body and mind are inextricably intertwined is more than just an abstraction.

19 Apr 2023

Gene therapy approach can decrease intraocular pressure in pre-clinical models of glaucoma

Scientists at Trinity College Dublin today announced a significant development towards a new therapeutic treatment of glaucoma.

19 Apr 2023

Researchers develop novel molecular nanocages for siRNA delivery

Small interfering RNAs (siRNAs) are novel therapeutics that can be used to treat a wide range of diseases.

19 Apr 2023

Clinical trial may set a new 'gold standard' for the treatment of childhood craniopharyngioma

St. Jude Children's Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with proton therapy.

19 Apr 2023

Could laughter yoga be a therapeutic approach for type 2 diabetic glycemic control?

Researchers investigated the effects of laughter yoga on glycemic control in people with type 2 diabetes.

19 Apr 2023

Talking therapies for depression may be linked to reduced rates of future cardiovascular disease

Using talking therapies to effectively treat depression in adults over the age of 45 may be linked with reduced rates of future cardiovascular disease, finds a new analysis of health data led by UCL researchers.

19 Apr 2023

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Researchers evaluated the effectiveness of endogenous metabolic modulator, AXA1125.

19 Apr 2023

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

This paper discusses the use of RNA lipid nanoparticles for cancer immunotherapy, which has shown promising results in clinical use. However, only a small percentage of patients respond to existing immunotherapies, and the paper explores opportunities for improvement.

18 Apr 2023

Binocular visual stimulation followed by sleep helps treat common vision problem in children

Amblyopia, sometimes called lazy eye, is a common vision problem in children and babies, and it’s typically been treated by having the child wear a patch on the stronger eye, with the goal of improving sight for the weaker eye.

18 Apr 2023

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers

Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of patients with rare cancers, are being reported for five cohorts of patients who had rare gynecologic cancers.

18 Apr 2023

New biologic inactivates potent opioid and reverses overdose

A new therapeutic designed by Scripps Research chemists can alter the molecular structure of the potent opioid carfentanil, inactivating the opioid and reversing a carfentanil overdose.

18 Apr 2023

Researchers discover the molecule responsible for guiding T cells toward tumors

Immunotherapy, particularly CAR T-Cell treatment for cancer, is extending the lives of many patients. But sometimes the therapy randomly migrates to places it shouldn't go, tucking into the lungs or other noncancerous tissue and causing toxic side effects.

18 Apr 2023

Therapy News and Research

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

Study explores the culture of antibiotic prescribing in US hospital ICUs

Houston-based cancer survivor donates $10 million to accelerate translational research and clinical trials

Using engineered stem cells to treat ALS and retinitis pigmentosa

Are high-power chargers for electric vehicles safe for individuals with cardiac implantable electronic devices?

Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

Mind-body linkage is built into the structure of the brain, study reveals

Gene therapy approach can decrease intraocular pressure in pre-clinical models of glaucoma

Researchers develop novel molecular nanocages for siRNA delivery

Clinical trial may set a new 'gold standard' for the treatment of childhood craniopharyngioma

Could laughter yoga be a therapeutic approach for type 2 diabetic glycemic control?

Talking therapies for depression may be linked to reduced rates of future cardiovascular disease

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

Binocular visual stimulation followed by sleep helps treat common vision problem in children

SWOG investigators report results from DART clinical trial of immunotherapy combination for rare gynecologic cancers

New biologic inactivates potent opioid and reverses overdose

Researchers discover the molecule responsible for guiding T cells toward tumors

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News